Anti-idiotypic antibodies induced by genetic immunisation are directed exclusively against combined VL/VH determinants
- 1 October 2001
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 8 (20) , 1555-1561
- https://doi.org/10.1038/sj.gt.3301546
Abstract
DNA vaccines encoding the idiotype of immunoglobulins of tumour B cells were shown to induce protection in several mouse lymphoma models. The mechanism of rejection of tumour cells has not been fully understood, but there is strong evidence suggesting that engagement of the idiotype by anti-idiotypic antibodies may directly result in inhibition of tumour growth. In this study, we have investigated the structural basis of the idiotypic/anti-idiotypic interaction following immunisation with DNA vaccines. scFvs containing only one of the two tumour-derived V regions recombined to an irrelevant V region partner were generated. These constructs encoding a secretory form of the scFv were used as immunogens to induce anti-Id antibodies. The same scFvs were expressed as membrane-bound molecules on the surface of mammalian cells. Analysis of immune sera on the membrane-displayed idiotypes revealed that DNA immunisation induced a polyclonal antibody response restricted to conformational combined epitopes formed by the parental VL/VH association. Immune sera raised by scFv DNA vaccination did not show any detectable reactivity towards chimeric scFvs containing only one of the two immunising V regions, indicating that the response against combined VL/VHdeterminants is highly dominant. Remarkably, the same immunogen, delivered as scFv protein, induced antibodies also directed against chain-specific determinants. These findings indicate that presentation of properly folded idiotypes results in a highly specific antibody response directed exclusively to private idiotypic determinants of the VL/VH combination of the immunogen.Keywords
This publication has 29 references indexed in Scilit:
- Anti-idiotypic DNA vaccines for lymphoma immunotherapy require the presence of both variable region genes for tumor protectionGene Therapy, 2000
- Setting the Standards: Quality Control in the Secretory PathwayScience, 1999
- The Two Membrane Isoforms of Human IgE Assemble into Functionally Distinct B Cell Antigen ReceptorsThe Journal of Experimental Medicine, 1996
- DNA immunization induces protective immunity against B–cell lymphomaNature Medicine, 1996
- Molecular Cloning and Characterization of a Transmembrane Surface Antigen in Human CellsEuropean Journal of Biochemistry, 1996
- Molecular characterization of a cross-reactive idiotope on human immunoglobulins utilizing the VH4-21 gene segment.The Journal of Experimental Medicine, 1993
- Monoclonal Antibodies Raised Against the Idiotype of the Murine B Cell Lymphoma, BCL1Act Primarily with Heavy Chain DeterminantsHybridoma, 1991
- Structural definition by antibody engineering of an idiotypic determinantProtein Engineering, Design and Selection, 1990
- Structure of idiotopes associated with antiphenylarsonate antibodies expressing an intrastrain crossreactive idiotype.The Journal of Experimental Medicine, 1989
- Spontaneous murine B-cell leukaemiaNature, 1978